腹腔镜胆囊切除术后恶心和吐发生率与用哈洛佩里多尔和丹塞进行预治疗的比较:随机临床试验研究
Ali Karami1, Elisa Ramadani, Mahsa Banifatemi
1Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
概括
在腹腔镜胆囊切除术后,Ondansetron和haloperidol在治疗术后恶心和吐方面表现出同等的有效性. 两种药物组之间的患者满意度和康复室停留时间相似.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 手术后恶心和吐 (PONV) 是手术后的常见并发症.
- 腹腔镜胆囊切除术与PONV的显著发病率有关.
研究的目的:
- 为了比较Ondansetron和Haloperidol在腹腔镜胆囊切除术后减轻恶心和吐的疗效.
- 为了评估患者的满意度和康复室停留时间,在接受丹塞或利的患者中.
主要方法:
- 一项随机临床试验,涉及60名接受选择性腹腔镜胆囊切除术的患者.
- 患者被分配给接受哈洛佩里多尔 (0.05毫克/公斤) 或丹塞 (0.15毫克/公斤).
- 经手术后的恶心和吐使用眼相对应量表进行评估;生命体征6小时监测;评估患者的满意度.
主要成果:
- 在康复室和病房中,哈洛佩里多尔和丹塞在减少恶心和吐方面表现出相似的效果.
- 对于恶心和吐的视觉模拟尺度得分,两组之间没有观察到统计学上显著的差异 (P = 0.58在康复中,P = 0.79在病房中).
- 在康复室停留的时间 (P = 0.19) 和患者满意度 (P = 0.82) 在halooperidol和ondansetron组之间没有显著差异.
结论:
- 利和丹塞在经腹腔镜胆囊切除术后的术后恶心和吐的治疗中同样有效.
- 两种药物都没有在患者满意度或对康复室停留时间的影响方面表现出优越性.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
288
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
288
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
84
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
84
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
277
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
277
Gastritis III: Clinical Manifestations and Management
246
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
246


